INTRODUCTION AND AIMS:
Fibrosis in the peritoneum is a major cause of ultrafiltration failure in continuous ambulatory peritoneal dialysis (CAPD) patients. 5-hydroxytryptamine (5-HT) induces extracellular matrix synthesis in interstitial fibroblasts in a Transforming growth factor beta 1 (TGF-b1) dependent manner. TGF-b1 is a major pro-fibrotic cytokine, which is essential in progressive changes in the peritoneal membrane leading to peritoneal fibrosis.To evaluate anti-fibrotic role of 5-HT2 and 5-HT2B inhibitors, Terguride and SB 204741, respectively in human peritoneal fibroblasts (HPFB) isolated from omentum and parietal peritoneum of CAPD patients. METHODS: Omentum biopsy (OB) of control patients (n¼6) undergone elective abdominal surgery and CAPD patients (n¼2) was incubated in 0.125% trypsin/0.01% EDTA twice for 20 minutes, twice for 40 minutes at 37 C. Parietal peritoneum biopsy (PB) excised during laparotomy was incubated overnight in dispase (2.4 U/mL)/37 C. HPFB appeared within 2 weeks. In disease mimicking strategy, HPFB from OB and PB were incubated with 5-HT-1mM for 1 hr and later with 5-HT-1mM and (Terguride, SB 204741-1mM, each) for 24 hr. In second strategy, HPFB from OB and PB were pretreated with (Terguride, SB 204741-1mM, each) for 1 hr and later with only 5-HT-1mM for 24 hr. HPFB were also incubated with TGF-b1-10ng/ml and 5-HT inhibitors similar to the above strategies. Real time quantitative PCR for pro-fibrotic Collagen Type I Alpha 1 Chain (Col1a1), Collagen Type I Alpha 2 Chain (Col1a2), Smooth Muscle Alpha (a)-2 actin (ACTA2), Connective Tissue Growth Factor (CTGF) and Fibronectin-1(FN1) genes and anti-fibrotic genes Matrix Metalloproteinase-2(MMP2), Tissue inhibitor of metalloproteinases-1(TIMP1) expression was performed. Type I collagen and Alpha Smooth Muscle Actin (a-SMA) was examined by western blotting. Phosphorylation status of Smad-3, Extracellular Signal Regulated Kinases (ERK1/2) and Signal Transducer and Activator of Transcription (STAT3) also was examined by immunoblotting. RESULTS: In 5-HT and TGF-b1stimulated HPFB, upregulated expression of profibrotic genes (p<0.05) mRNA at 24 hr was observed. Pre-treatment with Terguride and SB 204741 in the above stimulated HPFBs more effectively reduced pro-fibrotic genes expression (p<0.05) than disease mimicking strategies. Anti-fibrotic genes mRNA was not affected. 5-HT dose-dependently increased the mRNA levels of TGFb1. In 5-HT stimulated HPFB, pre-treatment with Terguride and SB204741 decreased type 1 collagen and a-SMA (p<0.05). However, in 5-HT stimulated HPFB, Terguride and SB 204741 pre-treatment did not influence Smad-3 phosphorylation (canonical pathway) rather reduced ERK1/2 and STAT3 phosphorylation (non-canonical pathway) (p<0.05) (Figure 1 , HPFB from peritoneum of CAPD Patients). CONCLUSIONS: 5-HT2 and 5-HT2B inhibitors reduce pro-fibrotic mRNA expression in 5-HT and TGF-b1stimulated HPFB by suppressing TGF-b1 mediated non-canonical pathway. 
FP492 ALANYL GLUTAMINE IN PERITONEAL DIALYSIS FLUID COUNTERACTS GDP INDUCED INADEQUATE ACTIVATION OF HSF1 IN MESOTHELIAL CELLS

INTRODUCTION AND AIMS:
Exposure of mesothelial cells to peritoneal dialysis fluids (PDF) results in cellular injury but also induces stress responses which can counteract PDF induced damage. Recent studies, however, suggest that PDF blocks the heat shock response, one of the evolutionary most important cellular stress responses. This study tested the hypothesis that cytoprotective stress responses may be inadequate in mesothelial cells exposed to standard heat sterilized PDF (H-PDF) due to the presence of glucose degradation products (GDPs), resulting in increased vulnerability against PDF cytotoxicity. METHODS: Human mesothelial cells were exposed to H-PDF or filter-sterilized PDF (without GDPs) or culture medium with or without concomitant heat stress. The induction of the cellular heat shock response was analyzed using the combined model of PDF exposure and heat stress (42 C) as the gold standard of stress induction. In addition, single (cytotoxic) components of PDF, like individual GDPs and acidosis as well as the impact of cytoprotective additives were investigated. Effects of GDPs on cellular viability, stress proteome and activation of the heat shock transcription factor HSF-1, heat shock proteins (HSPs) and stress kinases were assessed with and without addition of the cytoprotective dipeptide alanyl-glutamine (AlaGln). HSF-1 regulation was analyzed by use of a reportergene assay, nuclear shift analysis, the phosphorylation status, DNA-binding capacity, timer formation and Hsp72 induction among the different stressors. RESULTS: Exposure to H-PDF resulted in cellular damage but inadequate stress responses, with dampening of the stress proteome and reduced Hsp72 expression. Compared to heat, PDF leads to increased lethality but decreased Hsp72 expression. A concurrent blockage of the nuclear shift, phosphorylation and DNA-binding of HSF-1 with reduced activity of the promotor was found. GDPs at concentrations present in H-PDF (single and double chamber PD-fluid bags) blocked heat shock element (HSE) promoter-mediated transcriptional activity in mesothelial cells which was also associated with an inadequate increase of the activating phosphorylation of HSF1 at S326. The inadequate HSF-1 activation could be unblocked by filter-sterilized PDF (without GDPs) or addition of AlaGln. AlaGln restored HSF-1 activation and improved survival in a cell line and in patient-derived primary mesothelial cells via a specific glycosylation of upstream stress kinases of HSF-1. CONCLUSIONS: GDP mediated dampening of cellular stress responses via suppressed HSF-1 activation represents a novel pathomechanisms in PDF exposed mesothelial cells, and an attractive therapeutic target in PDF induced peritoneal damage. Supplementation of PDF with AlaGln restores the cytoprotective stress responses, resulting in improved resistance of mesothelial cells to PDF exposure. A functioning PD catheter is essential for a successful treatment. Currently, there is no evidence of better outcomes associated with a type of catheter or a catheter placement method. The aim of this study is to compare the outcomes of PD catheters placed by surgical versus percutaneous techniques, including catheter viability at 12 months, primary non-function and infectious complications METHODS: We performed a retrospective analysis from June 2007 to December 2017. Demographic and clinical patients' characteristics were evaluated, as well as the type of PD catheter placement, mechanical dysfunction and early (< 4 weeks) and late infectious complications. Uni-and multivariate analysis (t-test and logistic regression) and survival analysis (cox proportional hazards model) were performed. All PD catheters placed had an internal and external cuff. Percutaneously placed catheters were traditional Tenckhoff catheters, whereas surgically placed catheters were swan-neck catheters. RESULTS: A total of 203 PD catheter insertions were performed in 157 patients during the study period. PD was the first choice of RRT in 134 patients (85%). The median number of catheter per patient was 1 (range, 1 -4 catheters per patient). The mean age of patients was 51.4 6 17 years, 56% males. The mean body mass index (BMI) was 24.7 6 4.2 Kg/m2 and 30.6% had a history of abdominal surgery prior to DP catheter insertion. 28% (44 patients) had diabetes mellitus (DM). Only 4.5% (7 patients) had autosomal dominant polycystic kidney disease. 125 PD catheters were percutaneously placed (62%) by nephrologists. The remaining 78 PD catheters were surgically placed by surgeons. There was no significant difference in 1-year catheter survival in percutaneous vs surgical PD catheter placement (HR 0.8, p¼0.2). Catheter primary dysfunction did not differ significantly and the development of peritoneal leak was similar for both groups. Surgically placed PD catheters were statistically associated with more episodes of early infectious complications (26 episodes, p¼0.03). Adjusted for age, gender, BMI and presence/absence of DM, early infections remained more associated with surgical insertion technique and there was no difference in late infections between groups. Early use (< 2 weeks) of PD catheters was more frequent with percutaneously placed. PD catheter survival was higher in the presence of a helper (HR 1.8, p ¼ 0.08) and in laparoscopic placed PD catheters (HR 2.7, p ¼ 0.031). Late infection complication was associated with worse survival rate (HR 0.4, p < 0.001).
CONCLUSIONS:
The results showed that the catheter placement method did not affect 1-year catheter survival. Percutaneously placed PD catheters performed by nephrologists is a safe and effective method, with advantages of lesser waiting times, shorter break-in period and lower costs. 
INTRODUCTION AND AIMS:
In our clinical practice, it was curious to note that some patients after initiating peritoneal dialysis (PD) appeared to have changes in their biotype with a tendency for truncal obesity. To evaluate if this observation was accompained by body composition changes we have made a retrospective observational analysis. METHODS: We identified 42 patients that started and have at least 1 year follow-up on peritoneal dialysis between 2011 and 2017. Patients clinical and demographic characteristics were evaluated. The assessment of body composition was carried out using the Body Composition Monitor (BCM) portable device (Fresenius Medical Care) in three different times after begining the PD programe: 3 months, 6 months and 1 year. Measurements compared at this 3 times were overhydratation volume (OH); body mass index (BMI); lean tissue mass (LTM), lean tissue index (LTI), adipose tissue mass (ATM); fat tissue index (FTI) and body cell mass (BMC). Data was analyzed by using SPSS (Version 23 for Mac OSX). RESULTS: Patients median age was 51,6 6 11,6 years, 28 (66,7%) males, 10 (23,8%) had diabetes and 4 (9,5%) were obese (BMI>30Kg/m 2 ). Using Repeated Measures ANOVA Test, we compared body composition variables finding statistically significant variation over time (p<0,005) with Post Hoc confirmation in BMI (xD¼0,85Kg/m 2 , p¼0,008), LTI (xD¼-0,98 Kg/m 2 , p¼0,021), FTI (xD¼2,33 Kg/m 2 , p¼0,001), LTM (xD¼-3,24Kg, p¼0,001), ATM (xD¼5,74Kg, p¼0,001) and BCM (xD¼-1,90Kg, p¼0,019), between 3 months and 1 year. No significant variation was detected with OH. Neither age, diabetes or obesity influenced body composition parameters. In addition, between 3 months and 1 year of PD, a negative correlation was found between: LTI and ATM (r¼-0,73, p¼0,001) and FTI (r¼-0,63, p¼0,001); BCM and ATM (r¼-0,75, p¼0,001) and FTI (r¼-0,66, p¼0,001); LTM and ATM (r¼-0,83, p¼0,001) . At the same period a positive correlation was found between: BMI and FTI (r¼0,60, p¼0,001) and ATM (r¼0,59, p¼0,001); LTI and LTM (r¼0,92, p¼0,001) and BCM (r¼0,98, p¼0,001); BCM and LTM (r¼0, 94, p¼0, 001); FTI and ATM (r¼0, 96, p¼0, 001) . CONCLUSIONS: Our results demonstrate a redution in LTM, LTI and BCM accompanied by an increase in ATM, FTI and BMI supporting the hypothesis that PD induces a anticatabolic effect mainly on adipose tissue and a low protein turnover state with a negative muscle balance. However we are aware of the important limitation of our analysis with regard to sample size. There is a urgent require for further studies concerning to this matter, especially the prospective ones.
